The objective of the purposed studies is to determine the in vivo function(s) of intact prosaposin, a multifunctional precursor of four lysosomal hydrolase activator proteins, or saposins A,B, C and D. Isolated deficiencies of saposins B and C, or the total deficiency of prosapsoin lead to, respectively, one or several specific glycosphingolipids (GSL) stored in lysosomes of most organs, including the brain. Intact prosaposin has in vitro/ex vivo neurotrophic effects and GSL transport functions. When administered to animals, prosaposin has nerve regenerative properties. A specific 9-12 amino acid sequence of saposin C was identified as critical to the neurotrophic (NT) effects. Using a """"""""knock-out"""""""" (sap-/sap-) mouse, """"""""rescue"""""""" experiments are proposed using prosaposin transgenes designed so that the saposin functions are preserved, bu the in vitro/ex vivo NT functions are destroyed; i.e., the NT sequences will be normal [NT(+)] or mutant [NT(-)]. NT(+) and NT(-) prosaposins or their saposin C counterparts will be expressed heterologously in mammalian and insect cells, or E. coli, respectively. Prosaposins' processing to and turnover of saposins will be evaluated by metabolic labeling analyses. The cellular functions of the resultant saposins will be determined by quantitative GSL turnover, and sulfatide and glucosylceramide loading analyses. Purified prosaposins (insect source) and saposin Cs (E.coli) will be used to evaluate in vitro/ex vivo NT and GSL transport functions prior to making transgenic mice. The sap-/sap- mice expressing NT(+) or NT(-) prosaposins will have extensive histopathologic, biochemical (GSL and Western), immunofluorescence (prosaposin and saposins) and in situ mRNA hybridization analyses to determine the invivo function of the NT sequence. These studies are designed for direct correlations between the in vitro/ex vivo and in vivo functions of the transgenes and to define the minimal NT region necessary to prosaposins' trophic functions. Circumstantial in vitro/ex vivo evidence strongly supports a major role of intact prosaposin as a trophic, particularly neurotrophic, factor. It is the goal of these studies to define this potentially critical function in the only available system for these analyses. The results of these experiments have major import for understanding CNS development, nerve regeneration, GSL metabolism and the pathophysiology of GSL inborn errors of metabolism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS036681-02
Application #
2714644
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Spinella, Giovanna M
Project Start
1997-07-01
Project End
2002-05-30
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
León, Luis; Tatituri, Raju V V; Grenha, Rosa et al. (2012) Saposins utilize two strategies for lipid transfer and CD1 antigen presentation. Proc Natl Acad Sci U S A 109:4357-64
Sun, Ying; Liou, Benjamin; Xu, You-Hai et al. (2012) Ex vivo and in vivo effects of isofagomine on acid ?-glucosidase variants and substrate levels in Gaucher disease. J Biol Chem 287:4275-87
Xu, Y H; Sun, Y; Ran, H et al. (2011) Accumulation and distribution of ?-synuclein and ubiquitin in the CNS of Gaucher disease mouse models. Mol Genet Metab 102:436-47
Pearse, Bradley R; Tamura, Taku; Sunryd, Johan C et al. (2010) The role of UDP-Glc:glycoprotein glucosyltransferase 1 in the maturation of an obligate substrate prosaposin. J Cell Biol 189:829-41
Campeau, Philippe M; Rafei, Moutih; Boivin, Marie-Noelle et al. (2009) Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome. Blood 114:3181-90
Grabowski, Gregory A (2008) Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet 372:1263-71
Sun, Ying; Quinn, Brian; Xu, You-Hai et al. (2006) Conditional expression of human acid beta-glucosidase improves the visceral phenotype in a Gaucher disease mouse model. J Lipid Res 47:2161-70
Sun, Ying; Quinn, Brian; Witte, David P et al. (2005) Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants. J Lipid Res 46:2102-13
Sun, Ying; Qi, Xiaoyang; Grabowski, Gregory A (2003) Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation. J Biol Chem 278:31918-23
Sun, Ying; Witte, David P; Jin, Peng et al. (2003) Analyses of temporal regulatory elements of the prosaposin gene in transgenic mice. Biochem J 370:557-66

Showing the most recent 10 out of 15 publications